Central and peripheral nervous system toxicity of common chemotherapeutic agents

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00280-008-0876-6PMID 19034447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peripheral nerve damage associated with administration of taxanes in patients with cancer.

  2008influential reference
• Oxaliplatin-related neurotoxicity: interest of calcium-magnesium infusion and no impact on its efficacy.

  2008cited by this paper
• Thalidomide and sensory neurotoxicity: a neurophysiological study

  2008cited by this paper
• Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.

  2008cited by this paper
• Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.

  2008cited by this paper
• Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated.

  2008cited by this paper
• [Case of methotrexate encephalopathy: findings on diffusion tensor image and correlation with clinical outcome].

  2007cited by this paper
• Neurotoxicity of vincristine on the medial olivocochlear bundle.

  2007influential reference
• Acute Methotrexate-Induced Encephalopathy - Causal Relation to Homozygous Allelic State for MTR c.2756A>G (D919G)?

  2007cited by this paper
• Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity.

  2007cited by this paper
• Neuropathy in multiple myeloma treated with thalidomide

  2007cited by this paper
• Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate.

  2007cited by this paper
• Reversible posterior leukoencephalopathy syndrome after repeat intermediate‐dose cytarabine chemotherapy in a patient with acute myeloid leukemia

  2007cited by this paper
• [Ifosfamide induced encephalopathy: 15 observations].

  2006cited by this paper
• Reversible findings of restricted diffusion in 5-fluorouracil neurotoxicity.

  2006cited by this paper
• Psychiatric side effects of interferon treatment.

  2006cited by this paper
• Nonconvulsive Status Epilepticus Due to Ifosfamide

  2006cited by this paper
• Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation.

  2006cited by this paper
• Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring.

  2006cited by this paper
• Encéphalopathie induite par l'ifosfamide : 15 observations

  2006cited by this paper
• Evaluating Risk Factors for the Development of Ifosfamide Encephalopathy

  2005cited by this paper
• Neurological toxicity of long‐term (>1 yr) thalidomide therapy in patients with multiple myeloma

  2005cited by this paper
• Chemotherapy-induced peripheral neuropathy.

  2005cited by this paper
• Unusual causes of hyperammonemia in the ED.

  2004cited by this paper
• Vascular Neurotoxicity Following Chemotherapy with Cisplatin, Ifosfamide, and Etoposide

  2004cited by this paper
• Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation.

  2004cited by this paper
• Neurophysiological Study of Peripheral Neuropathy after High-Dose Paclitaxel

  2004cited by this paper
• Central neurotoxicity of cyclosporine in two children with nephrotic syndrome

  2004cited by this paper
• Methotrexate-Induced Leukoencephalopathy Reversed by Aminophylline and High-Dose Folinic Acid

  2004cited by this paper
• Isolated abducens nerve palsy induced by vincristine therapy.

  2004cited by this paper
• Reversible posterior leucoencephalopathy during oral treatment with methotrexate

  2004cited by this paper
• Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation.

  2004influential reference
• Treatment-induced leukoencephalopathy in primary CNS lymphoma

  2004cited by this paper
• Ifosfamide-induced encephalopathy with or without using methylene blue

  2004cited by this paper
• Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy.

  2003cited by this paper
• α‐tocopherol protects against cisplatin‐induced toxicity without interfering with antitumor efficacy

  2003cited by this paper
• Progressive Multifocal Leukoencephalopathy in Chronic Lymphocytic Leukemia after Treatment With Fludarabine

  2002cited by this paper
• [Psychiatric sequelae of interferon-alpha therapy].

  2002cited by this paper
• Chemotherapy-induced peripheral neuropathy

  2002cited by this paper
• Acute transient encephalopathy after paclitaxel infusion: report of three cases.

  2002cited by this paper
• Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracil

  2001cited by this paper
• Reversible posterior leucoencephalopathy syndrome associated with bone marrow transplantation.

  2001cited by this paper
• Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis

  2001influential reference
• A pilot study on the relation between cisplatin neuropathy and vitamin E.

  2001cited by this paper
• Progressive multifocal leukoencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia

  2000cited by this paper
• Paclitaxel does not cause central nervous adverse effects: a prospective vigilance-controlled EEG mapping study in ovarian cancer patients.

  2000cited by this paper
• Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome.

  1998cited by this paper
• An Overview of Cyclophosphamide and Ifosfamide Pharmacology

  1997cited by this paper
• [Acute cerebellar syndrome after treatment with 5-fluorouracil].

  1996cited by this paper
• Syndrome cérébelleux aigu après traitement par le 5-fluorouracile.

  1996cited by this paper
• Transient encephalopathy after paclitaxel (Taxol) infusion

  1996cited by this paper
• Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency.

  1996cited by this paper
• Subacute encephalopathic toxicity of cisplatin.

  1995cited by this paper
• Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.

  1994cited by this paper
• Filamentous degeneration of neurons. A possible feature of cytosine arabinoside neurotoxicity

  1993cited by this paper
• High-dose cytarabine neurotoxicity: MR findings during the acute phase.

  1993cited by this paper
• Persistent neurotoxicity of systemically administered interferon‐alpha

  1991cited by this paper
• Reversible encephalopathy and seizures as a result of conventional vincristine administration.

  1988cited by this paper
• The neurotoxicity of high‐dose cytosine arabinoside is age‐related

  1987cited by this paper
• Central nervous system toxicity of fludarabine phosphate.

  1986cited by this paper
• Central nervous system toxicity of fludarabine phosphate.

  1986cited by this paper
• Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological study.

  1986cited by this paper

• Neurotoxicity of chemotherapeutic agents: mechanisms and mitigation strategies.

  2026cites this paper
• Redefining Chemotherapy-Related Headaches: From Pathobiology to Differential Diagnosis and Management

  2025cites this paper
• Effect of hematopoietic stem cell transplantation on meibomian gland structure.

  2025cites this paper
• Cancer-related movement disorders: A scoping review and diagnostic approach.

  2025cites this paper
• Wearable bioelectronics for cancer theranostics

  2025cites this paper
• Identification of Npas4 as a biomarker for CICI by transcriptomics combined with bioinformatics and machine learning approaches.

  2025cites this paper
• Complications of Chemotherapy.

  2025cites this paper
• Neuroleukemiosis Masquerading as Drug Toxicity in an Adolescent With Refractory AML

  2025cites this paper
• Drug carrier-assisted combined chemo- and radionuclide therapy for tumors of diverse origins: effects of therapeutic schemes on tumor responses.

  2025cites this paper
• Management of Cisplatin-Induced Encephalopathy: A Case Report and Literature Review

  2024cites this paper
• Development of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3.

  2024cites this paper
• Neurologic dance training and home exercise improve motor-cognitive dual-task function similarly, but through potentially different mechanisms, among breast cancer survivors with chemotherapy-induced neuropathy: Initial results of a randomized, controlled clinical trial

  2024influential citation
• Diagnostic and Treatment Approaches to Chemo Brain

  2024cites this paper
• Drug-induced psychotic syndrome

  2024cites this paper
• A genetic variant study of bortezomib-induced peripheral neuropathy in Chinese multiple myeloma patients

  2024cites this paper
• Postoperative Nausea and Vomiting in Female Patients Undergoing Laparoscopic Gastrointestinal Surgery with Double Prophylactic Therapy

  2024cites this paper
• Opportunities for nanomaterials in enzyme therapy.

  2024cites this paper
• Polymer-Based Nanoparticles as Drug Delivery Systems for Purines of Established Importance in Medicine

  2023cites this paper
• 5-Fluorouracil-induced leukoencephalopathy

  2023cites this paper
• Chemotherapy-Induced Leukoencephalopathy Revealed by Seizure and Alteration of the Mental Status

  2023cites this paper
• Risk of seizures in a population of women with BRCA-positive metastatic breast cancer from an electronic health record database in the United States

  2023cites this paper
• Streptomyces Bioactive Metabolites Prevent Liver Cancer through Apoptosis, Inhibiting Oxidative Stress and Inflammatory Markers in Diethylnitrosamine-Induced Hepatocellular Carcinoma

  2023cites this paper
• Alkaline phosphatase (ALP) activatable small molecule-based prodrugs for cancer theranostics.

  2023cites this paper
• Chemotherapy-induced neuronal DNA damage: an intriguing toolbox to elucidate DNA repair mechanisms in the brain

  2023cites this paper
• Effectiveness of a Computerized Home-Based Cognitive Stimulation Program for Treating Cancer-Related Cognitive Impairment

  2023cites this paper
• Roles of trans-lesion synthesis (TLS) DNA polymerases in tumorigenesis and cancer therapy

  2023cites this paper
• Chemotherapy and cognitive function: comprehensive review on methotrexate‐induced chemobrain

  2023cites this paper
• Effect of neoadjuvant chemotherapy on effect-site concentration of propofol for sedation in patients with breast cancer

  2023cites this paper
• Antiproliferative and Apoptotic Effects of Olive Leaf Extract Microcapsules on MCF-7 and A549 Cancer Cells

  2023cites this paper
• Vincristine‑induced peripheral neuropathy in children with acute lymphoblastic leukemia: Clinical and instrumental characteristics, search for new solutions

  2023cites this paper
• Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers

  2022cites this paper
• Delayed Post-Hypoxic Leukoencephalopathy Following Nitrite Poisoning: A Case Report and Review of the Literature

  2022cites this paper
• Evaluation of Toxic Effects of Chemotherapy in Lung Malignancies on Cerebral White Matter Using Diffusion Tensor Imaging

  2022cites this paper
• The Neuroprotective and Antinociceptive effect of Antidiabetic 3-(2-chlorophenyl)-4-imino-5-phenyl-2-(2-methoxyphenyl)-2H,3H,5H-[1,2,5]thiadiazolidin-1-oxide (CIPMTO) in Streptozotocin-induced diabetic neuropathic pain in rats: primary proof of concept

  2022cites this paper
• Chemotherapy-Related Structural Changes in Cancer: Effect of GnRH Antagonist in the Ovarian Follicles

  2022cites this paper
• Prevention of anticancer therapy-induced neurotoxicity: putting DNA damage in perspective.

  2022cites this paper
• Chemotherapy-induced acute reversible toxic leukoencephalopathy

  2022cites this paper
• The Functional Observation Battery: Utility in Safety Assessment of New Molecular Entities

  2021cites this paper
• Bioactive extract of Fomitopsis pinicola rich in 11-α- acetoxykhivorin mediates anticancer activity by cytotoxicity, induction of apoptosis, inhibition of tumor growth, angiogenesis and cell cycle progression

  2021cites this paper
• The safety of current pharmacotherapeutic strategies for osteosarcoma

  2021cites this paper
• A review of movement disorders in chemotherapy-induced neurotoxicity

  2021cites this paper
• Central Nervous System Complications Among Oncology Patients.

  2021cites this paper
• Assessment of the Efficacy of Olive Leaf (Olea europaea L.) Extracts in the Treatment of Colorectal Cancer and Prostate Cancer Using In Vitro Cell Models

  2021cites this paper
• Biological evaluation and molecular docking of novel 1,3,4-thiadiazole-resorcinol conjugates as multifunctional cholinesterases inhibitors.

  2021cites this paper
• Acute Disseminated Encephalomyelitis Following Chemoradiotherapy in an Adult Patient With Nasopharyngeal Cancer

  2021cites this paper
• Cancer Rehabilitation

  2021cites this paper
• Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932

  2021cites this paper
• Effect of chemotherapy on effect-site concentration of propofol for loss of consciousness in patients with colorectal cancer

  2021cites this paper
• Tumortherapieassoziierte neurologische Symptome

  2021cites this paper
• Roles of RAD18 in DNA replication and post-replication repair (PRR)

  2021cites this paper
• Anti-neoplastic agents for patients on peritoneal dialysis: A systematic review.

  2020cites this paper
• Spatial memory deficits after vincristine-induced lesions to the dorsal hippocampus

  2020cites this paper
• Complex Metal Ions: Neuropsychiatric and Imaging Features.

  2020cites this paper
• Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies.

  2020cites this paper
• Chemotherapy-Induced Peripheral Neuropathy

  2020cites this paper
• Neurologic Complications

  2020cites this paper
• The Neuroprotective Effect of Mesna on Cisplatin-Induced Neurotoxicity: Behavioral, Electrophysiological, and Molecular Studies

  2020cites this paper
• MRI ROLE IN CHEMOTHERAPEUTIC INDUCED PRES

  2020cites this paper
• Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis.

  2020cites this paper
• Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.

  2020cites this paper
• Investigating fine motor deficits during maintenance therapy in children with acute lymphoblastic leukemia

  2020cites this paper
• Acute Neurological Complications of Brain Tumors and Immune Therapies, a Guideline for the Neuro-hospitalist

  2020cites this paper
• Study of Chemotherapy-Induced Cognitive Impairment in Women with Breast Cancer

  2020cites this paper
• Effects of thioTEPA chemotherapy on cognition and motor coordination

  2019cites this paper
• Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer

  2019cites this paper
• Delirium and seizures in a patient with head-and-neck squamous cell carcinoma on docetaxel, cisplatin, and 5-fluorouracil

  2019cites this paper
• Apremilast ameliorates carfilzomib‐induced pulmonary inflammation and vascular injuries

  2019cites this paper
• The Effects of Agomelatine on The Biochemical and Pathological Features of Cisplatin-Induced Peripheral Neuropathy: The First Experimental Study in Rats.

  2019cites this paper
• Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases

  2019cites this paper
• Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options

  2019cites this paper
• Frequency of lethal central nervous system neurotoxicity in patients undergoing allogeneic stem cell transplantation: a retrospective registry analysis

  2019cites this paper
• Head Trauma and Brain Tumors

  2019cites this paper
• A geriatric patient with spinal cord injury without radiographic abnormality: outcomes and causes

  2018cites this paper
• 29 – Cancer Rehabilitation

  2018cites this paper
• Cancer Rehabilitation

  2018cites this paper
• Neurotoxicity of cytarabine (Ara‐C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function

  2018cites this paper
• Effects of neoadjuvant chemotherapy on the depth of total intravenous anesthesia in patients with breast cancer undergoing unilateral modified radical mastectomy

  2018influential citation
• Incidence, severity, longitudinal trends and predictors of acute and chronic oxaliplatin‐induced peripheral neuropathy in Taiwanese patients with colorectal cancer

  2018cites this paper
• Optical examination of the efficacy of contact needle therapy for chemotherapy-induced peripheral neuropathy: integration of inspection in Kampo therapy with color spectrum information

  2018cites this paper
• Stratégie thérapeutique des neuropathies périphériques chimio-induites

  2018cites this paper
• Zytostatika-assoziierte Toxizitäten in der geriatrischen Onkologie

  2018cites this paper
• Longitudinal analysis of quality‐of‐life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial

  2018cites this paper
• Fueling the FIRES: Hemophagocytic lymphohistiocytosis in febrile infection‐related epilepsy syndrome

  2018cites this paper
• PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates

  2018cites this paper
• High-throughput screen for compounds that modulate neurite growth of human induced pluripotent stem cell-derived neurons

  2018cites this paper
• Sensitization of TRPV1 receptors by TNF-α orchestrates the development of vincristine-induced pain

  2018cites this paper
• The role of matrix metalloproteinases in cancer progression, in particular metastasis

  2018cites this paper
• Stroke in Critically Ill Cancer Patients

  2018cites this paper
• Impaired thiol-disulphide homeostasis in patients with axonal polyneuropathy

  2018cites this paper
• MR Imaging Features of Chemotherapeutic Neurotoxicity in Cancer Patient

  2017cites this paper
• Neurotoxicity Associated with Platinum-Based Anti-Cancer Agents: What are the Implications of Copper Transporters?

  2017cites this paper
• MRI in Chemotherapy induced Leukoencephalopathy: Report of Two Cases and Radiologist's Perspective.

  2017cites this paper
• Severe Reversible Form of Chemotherapy Induced Acute Disseminated Leukoencephalopathy: A Case Report with Review of Literature

  2017cites this paper
• Neurotoxicity Associated with Cancer Treatment

  2017cites this paper
• Effect of Cognitive Training Program in Chemotherapy Treated Breast Cancer patients

  2017cites this paper
• Cardiac autonomic functioning is impaired among allogeneic hematopoietic stem cell transplantation survivors: a controlled study

  2017cites this paper
• Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

  2017cites this paper
• Management of neuro-oncologic emergencies.

  2017cites this paper
• Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review

  2017cites this paper
• Brain and the Drug Transporters

  2017cites this paper